Persistence, Adherence and Clinical Effectiveness of Entecavir in Chronic Hepatitis B Patients

Bristol-Myers Squibb (BMS)

Status: Completed

Conditions: Hepatitis B, Chronic

Study type: Observational

Funder types: Industry

Identifiers

NCT01356901

AI463-232

Details and patient eligibility

About

The purpose of this observational study is to measure the real-life persistence, adherence and clinical effectiveness of entecavir in patients with chronic Hepatitis B viral infection.

Full description

Sampling Method: Probability Sample (consecutive patient sampling)

Enrollment: 230 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Male and female treatment naïve or pre-treated CHB patients of at least 18 years of age
• Written informed consent

Exclusion criteria

• All relevant conditions according to Summary of product characteristics (SmPC)
• Human immunodeficiency virus (HIV), Hepatitis C virus (HCV) or Hepatitis D virus (HDV) co-infection
• Patients currently included in any investigational trial on CHB

Trial design

230 participants in 1 patient group

Treatment naïve and pre-treated CHB patients

Description:

subanalysis with migrant and non-migrant patients